{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:28Z","timestamp":1792785868451,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Nagoya University CIBoG WISE program","id":[{"id":"https:\/\/ror.org\/04chrp450","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JST BOOST"},{"DOI":"10.13039\/501100001695","name":"JST","doi-asserted-by":"publisher","award":["JPMJBS2422"],"award-info":[{"award-number":["JPMJBS2422"]}],"id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Clinical guidelines recommend follow-up quantitative testing after dipstick-positive proteinuria and, when proteinuria is confirmed, subsequent initiation of renin\u2013angiotensin system inhibitors (RASi) in patients with hypertension. However, real-world adherence to these recommendations remains unclear. We investigated management patterns following newly detected dipstick proteinuria in patients with treated hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using the JMDC claims database, we identified treated hypertensive patients with newly detected dipstick proteinuria (\u22651+, with prior results &amp;lt;1+) between January 2005 and March 2025. The study outcomes were quantitative urine albumin\/protein testing and RASi initiation. Cumulative incidence was estimated using the Kaplan\u2013Meier method, and multivariable Cox models were used to identify factors associated with outcomes. The 365-day cumulative incidence of quantitative testing was 7.5% [95% confidence interval (CI): 7.2\u20137.7] in the overall population (n = 47 210), and that of RASi initiation was 13.2% (95% CI: 12.6\u201313.8) among baseline RASi non-users (n = 14 599). Both outcomes became more frequent with increasing dipstick grade but remained infrequent in the higher-grade groups: among patients with 2+ and 3+ proteinuria, quantitative testing was performed in 12.9 and 16.1%, respectively, and RASi initiation occurred in 17.5 and 21.7%, respectively. Temporal trend analysis indicated that RASi initiation rates showed no improvement (adjusted hazard ratio [aHR] per year: 1.01; 95% CI: 0.99\u20131.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Follow-up quantitative testing and RASi initiation after newly detected dipstick proteinuria were infrequent, even among patients with higher dipstick grades, and RASi initiation showed no clear improvement over time. These findings highlight opportunities to improve guideline-concordant urinary protein assessment and antihypertensive therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcag144","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:09:33Z","timestamp":1789384173000},"source":"Crossref","is-referenced-by-count":0,"title":["Care gaps following newly detected dipstick proteinuria in treated hypertension: a Japanese nationwide database study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-098X","authenticated-orcid":false,"given":"Koya","family":"Nagase","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-7241","authenticated-orcid":false,"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]},{"name":"Department of Clinical Research Education, Nagoya University Graduate School of Medicine , 65, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3589-698X","authenticated-orcid":false,"given":"Yuko","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]},{"name":"Department of Clinical Research Education, Nagoya University Graduate School of Medicine , 65, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Mitsubayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-1205","authenticated-orcid":false,"given":"Nobuhiro","family":"Nishibori","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1839-1180","authenticated-orcid":false,"given":"Takaya","family":"Ozeki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]},{"name":"Kanayama Internal Medicine Clinic , 1-14-9 Kanayama, Naka-ku, Nagoya, Aichi 460-0022 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3711-3925","authenticated-orcid":false,"given":"Masaki","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]},{"name":"Department of Clinical Research Education, Nagoya University Graduate School of Medicine , 65, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]},{"name":"Department of Nephrology, Shinseikai Daiichi Hospital , 1302 Takamiya, Tempaku-ku, Nagoya, Aichi 468-0031 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-2380","authenticated-orcid":false,"given":"Shimon","family":"Kurasawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5189-9584","authenticated-orcid":false,"given":"Tsuyoshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kou Hospital , 36-1, Hazenji, Kubo-cho, Toyokawa, Aichi 442-0856 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2476-688X","authenticated-orcid":false,"given":"Kazuhiro","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-632X","authenticated-orcid":false,"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine , 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"2026092407565522100_qcag144-B1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2026092407565522100_qcag144-B2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"key":"2026092407565522100_qcag144-B3","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026092407565522100_qcag144-B4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2478\/jtim-2020-0033","article-title":"Pathogenesis and damage targets of hypertensive kidney injury","volume":"8","author":"Sun","year":"2020","journal-title":"J Transl Int Med"},{"key":"2026092407565522100_qcag144-B5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1172\/JCI111349","article-title":"Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension","volume":"73","author":"Dworkin","year":"1984","journal-title":"J Clin Invest"},{"key":"2026092407565522100_qcag144-B6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest"},{"key":"2026092407565522100_qcag144-B7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCULATIONAHA.124.071079","article-title":"Albuminuria in cardiovascular, kidney, and metabolic disorders: a state-of-the-art review","volume":"151","author":"Claudel","year":"2025","journal-title":"Circulation"},{"key":"2026092407565522100_qcag144-B8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"key":"2026092407565522100_qcag144-B9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","article-title":"Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study","volume":"45","author":"Ibsen","year":"2005","journal-title":"Hypertension"},{"key":"2026092407565522100_qcag144-B10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijcard.2014.01.065","article-title":"Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and\/or diabetic patients: a meta-regression analysis of 32 randomized trials","volume":"172","author":"Savarese","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026092407565522100_qcag144-B11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/HJH.0000000000000991","article-title":"Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis","volume":"34","author":"Viazzi","year":"2016","journal-title":"J Hypertens"},{"key":"2026092407565522100_qcag144-B12","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026092407565522100_qcag144-B13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/j.ajkd.2024.09.017","article-title":"Methods for diagnosing proteinuria-when to use which test and why: a review","volume":"85","author":"Hodel","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B14","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1681\/ASN.2010111217","article-title":"Dipstick proteinuria as a screening strategy to identify rapid renal decline","volume":"22","author":"Clark","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026092407565522100_qcag144-B15","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s10157-025-02703-x","article-title":"Efficacy of screening with dipstick urinalysis in predicting renal function decline in healthy workers: a 10-year follow-up study","volume":"29","author":"Suka","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"2026092407565522100_qcag144-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-018-1648-1","article-title":"Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018","volume":"23","author":"Japanese Society of Nephrology","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2026092407565522100_qcag144-B17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"2026092407565522100_qcag144-B18","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2026092407565522100_qcag144-B19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jgf2.422","article-title":"Data resource profile: JMDC claims database sourced from health insurance societies","volume":"22","author":"Nagai","year":"2021","journal-title":"J Gen Fam Med"},{"key":"2026092407565522100_qcag144-B20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jclinepi.2006.01.009","article-title":"Using the outcome for imputation of missing predictor values was preferred","volume":"59","author":"Moons","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2026092407565522100_qcag144-B22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"2026092407565522100_qcag144-B23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s40471-020-00243-4","article-title":"A selective review of negative control methods in epidemiology","volume":"7","author":"Shi","year":"2020","journal-title":"Curr Epidemiol Rep"},{"key":"2026092407565522100_qcag144-B24","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","year":"2021","journal-title":"Hypertension"},{"key":"2026092407565522100_qcag144-B25","article-title":"ACEI\/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study)","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One"},{"key":"2026092407565522100_qcag144-B26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/HYPERTENSIONAHA.120.16281","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use among hypertensive US adults with albuminuria","volume":"77","author":"Chu","year":"2021","journal-title":"Hypertension"},{"key":"2026092407565522100_qcag144-B27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41440-024-01896-0","article-title":"Current use of angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors for hypertension in patients with chronic kidney disease with proteinuria: a cross-sectional study based on real-world data","volume":"48","author":"Tada","year":"2025","journal-title":"Hypertens Res"},{"key":"2026092407565522100_qcag144-B28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10157-006-0458-z","article-title":"Clinical utility of trace proteinuria for microalbuminuria screening in the general population","volume":"11","author":"Konta","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"2026092407565522100_qcag144-B29","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.12688\/f1000research.25564.1","article-title":"Diagnostic accuracy of a urine dipstick for detecting albuminuria in hypertensive patients","volume":"9","author":"Panta","year":"2020","journal-title":"F1000Res"},{"key":"2026092407565522100_qcag144-B30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"key":"2026092407565522100_qcag144-B31","doi-asserted-by":"crossref","first-page":"11986","DOI":"10.1038\/s41598-017-12057-4","article-title":"Dipstick proteinuria and risk of myocardial infarction and all-cause mortality in diabetes or pre-diabetes: a population-based cohort study","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"2026092407565522100_qcag144-B32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2169\/internalmedicine.46.6415","article-title":"Analysis of factors causing hyperkalemia","volume":"46","author":"Takaichi","year":"2007","journal-title":"Intern Med"},{"key":"2026092407565522100_qcag144-B33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jch.12795","article-title":"Acute kidney injury in elderly patients with chronic kidney disease: do angiotensin-converting enzyme inhibitors carry a risk?","volume":"18","author":"Chaumont","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026092407565522100_qcag144-B34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jash.2014.08.015","article-title":"Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD)","volume":"8","author":"Ljungman","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"2026092407565522100_qcag144-B35","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B36","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10157-009-0237-8","article-title":"Evidence-based practice guideline for the treatment of CKD","volume":"13","author":"Japanese Society of Nephrology","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"2026092407565522100_qcag144-B38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11255-017-1679-7","article-title":"The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis","volume":"50","author":"Shi","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"2026092407565522100_qcag144-B39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ki.2013.96","article-title":"Audit-based education lowers systolic blood pressure in chronic kidney disease: the quality improvement in CKD (QICKD) trial results","volume":"84","author":"de Lusignan","year":"2013","journal-title":"Kidney Int"},{"key":"2026092407565522100_qcag144-B40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.ajkd.2020.05.013","article-title":"Electronic decision support for management of CKD in primary care: a pragmatic randomized trial","volume":"76","author":"Peralta","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.ajkd.2016.01.022","article-title":"Educational interventions for patients with CKD: a systematic review","volume":"68","author":"Lopez-Vargas","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.ajkd.2018.01.058","article-title":"Impact of a primary care CKD registry in a US public safety-net health care delivery system: a pragmatic randomized trial","volume":"72","author":"Tuot","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026092407565522100_qcag144-B43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2486\/indhealth.2017-0104","article-title":"Factors associated with adherence to recommendations to visit a physician after annual health checkups among Japanese employees: a cross-sectional observational study","volume":"56","author":"Goto","year":"2018","journal-title":"Ind Health"},{"key":"2026092407565522100_qcag144-B44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2188\/jea.JE20180192","article-title":"Utility of a specific health checkup database containing lifestyle behaviors and lifestyle diseases for employee health insurance in Japan","volume":"30","author":"Fukasawa","year":"2020","journal-title":"J Epidemiol"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag144\/71228847\/qcag144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcag144\/71228847\/qcag144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:57:13Z","timestamp":1790251033000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article\/doi\/10.1093\/ehjqcco\/qcag144\/8817583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcag144","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"article-number":"qcag144"}}